Pharmacy Technology & Management Review
Pharmacy Technology & Management Review Audio Content
Navigating The Pharmacy Legal And Regulatory Landscape in 2025
Preview
0:00
Current time: 0:00 / Total time: -3:51
-3:51

Navigating The Pharmacy Legal And Regulatory Landscape in 2025

Pocast | A conversation with Frier Levitt Partner Jesse Dresser covering the outlook for PBM reform, what to look for in compounding regulation, and more... LISTEN NOW!

Guest: Jesse Dresser, Partner at Frier Levitt

About Jesse Dresser

Jesse Dresser is a partner at Frier Levitt and heads the firm's pharmacy practice group. He has extensive experience advising pharmacies on a wide range of legal and regulatory matters, including PBM disputes, compounding regulations, and compliance issues.

Jesse Dresser, Partner at Frier Levitt
Jesse Dresser, Partner at Frier Levitt

Host: Will Lockwood, Editor, PTMReview

Episode Summary

Thanks for reading Pharmacy Technology & Management Review! This post is public so feel free to share it.

Share

In this episode, we talk about the key legal and regulatory issues facing the pharmacy industry in 2025 and beyond. Our guest, Jesse Dresser, a seasoned expert in pharmacy law, provides insights into the following topics:

  • PBM Reform: We discuss the ongoing efforts to reform Pharmacy Benefit Managers (PBMs) and the potential impact of federal and state legislation.

  • Pharmacy Compounding: We explore the resurgence of pharmacy compounding, particularly in light of drug shortages, and…

Listen to this episode with a 7-day free trial

Subscribe to Pharmacy Technology & Management Review to listen to this post and get 7 days of free access to the full post archives.

Pharmacy Technology & Management Review
Pharmacy Technology & Management Review Audio Content
Pharmacy Technology & Management Review keeps pharmacists, pharmacy technicians, and industry stakeholders on top of the latest trends, emerging technologies, and best practices in the dynamic and evolving pharmacy market.
Here's where you can listen to our content.